Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abivax, Cabaletta, Genmab, Junshi, Pfizer, Regeneron, Revance, Tyra.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abeona, Adaptimmune, Biosyngen, Cytodyn, Neurobo, Theradaptive.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: 23andme, Astellas, Biontech, Cel-Sci, Daré, Defender, Duality, Ensysce, Jaguar Gene Therapy, Janssen, Vanda.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Illuminoss.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bristol Myers Squibb, Cellvax, Cidar, Eilean, Halozyme, Hutchmed, Inmune, Gilead, Kite, Lexaria, Microbion, Neoimmunetech, Pfizer, Revolo, Takeda.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Inspiremd, Kuros, Philips, Gore.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: AB Science, Ascidian, Astellas, Astrazeneca, Celltrion, Daewoong, Daiichi, Gracell, GSK, Halozyme, Oricell, Takeda, Tonix.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bruin Biometrics, Copan, Magstim, Nuvoair, Si-Bone, Tyber.
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Biosion, Caliway, GC iopharma, Eisai, Innocare, Unibio.
RSS